Trial Profile
Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms PROFACE
- 10 Apr 2012 New source identified and integrated (Clinicaltrials.gov record NCT01570530).
- 16 Jun 2011 New trial record